Progress in the maturity of the start-ups: the clinical phases

by GENESIS Biomed

The start-ups Oxolife, Peptomyc and aptaTargets, with which GENESIS Biomed collaborates, are advancing in their maturity with the initiation and development of clinical phases and are approaching an e...

Read more

EIT Health Investors Network: a key opportunity for start-ups in search of funding

by GENESIS Biomed

AseBio Investor Day’s round table on fundraising in Europe gathered EIT Health Investor Network’s main stakeholders

Read more

IQS Tech Factory lanza las 'Talk Series', diálogos con líderes de innovación industrial

by IQS Institut Químic de Sarrià

IQS Tech Factory ha lanzado las “Talk Series. Industrial Innovators Dialogues”, una serie de diálogos entre Oriol Pascual, director de IQS Tech​ Factory, y líderes del ecosistema de la innovac...

Read more

Tres proyectos del IDIBAPS – Hospital Clínic, seleccionados para el programa “The Collider” de Mobile World Capital

by Fundació Clínic per a la Recerca Biomèdica

The Collider es una iniciativa de Mobile World Capital Barcelona que busca conectar el conocimiento científico con el talento emprendedor para crear start-ups tecnológicas en ámbitos como digital h...

Read more

Catalan biomedical companies attracted €106 million in investment in 2018 for new drugs and technology

by CataloniaBio

Venture capital funds continue to lead investment, but there is growing interest in the sector from business angels. 60% of Catalan pharmaceutical groups invest in start-ups to fuel open innovation.

Read more

Inbiomotion and Peptomyc receive funding through European Horizon 2020 program

by Biocat

In the final round of selection, the European Horizon 2020 has chosen two Catalan start-ups from the health sector: Inbiomotion and Peptomyc, which will receive €50,000 to fund their innovative proj...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Investigadores del VHIR desarrollan un c...

by Vall d’Hebron

El BiofilmChip es un dispositivo que permite un diagnóstico personali...

Photos Stream